BamSEC and AlphaSense Join Forces
Learn More

TerrAscend Corp

OTC: TSNDF    
Share price (11/22/24): $0.77    
Market cap (11/22/24): $273 million

Material Contracts Filter

EX-10.1
from 10-Q 10 pages Unit Purchase Agreement
12/34/56
EX-10.33
from 10-K 5 pages TerrAscend Corp. – Share Unit Agreement
12/34/56
EX-10.32
from 10-K 21 pages TerrAscend Corp. Amended and Restated Share Unit Plan
12/34/56
EX-10.31
from 10-K 6 pages TerrAscend Corp. – Stock Option Agreement
12/34/56
EX-10.30
from 10-K 24 pages TerrAscend Corp. Amended and Restated Stock Option Plan (Adopted by the Board as of March 8, 2017, as Amended and Restated on November 2, 2021, April 19, 2023, June 22, 2023 and June 26, 2023) Definitions and Interpretation
12/34/56
EX-10.15
from 10-K 299 pages Wdb Holding Pa, Inc
12/34/56
EX-10.12
from 10-K 44 pages Debt Settlement Agreement This Agreement Is Made as of December 9, 2022 (The “Settlement Date”) Between: TerrAscend Corp., a Corporation Incorporated Under the Laws of the Province of Ontario (“Terrascend”) and - Arise Bioscience, Inc., a Corporation Existing Under the Laws of the State of Delaware (“Arise”) and - TerrAscend Canada Inc., a Corporation Incorporated Under the Laws of the Province of Ontario (“Terrascend Canada” and Together With Arise, the “Debt Issuers”) and - Canopy USA, LLC, a Limited Liability Company Existing Under the Laws of the State of Delaware (“Canopy USA”) and - Canopy USA I Limited Partnership, a Limited Partnership Existing Under the Laws of the Province of Ontario (“Canopy USA LP I”) and - Canopy USA III Limited Partnership, a Limited Partnership Existing Under the Laws of the Province of Ontario (“Canopy USA LP III”, Together With Canopy USA LP I, the “Canopy USA Lps” And, Together With Canopy USA, the “Canopy USA Entities”) Whereas: A
12/34/56
EX-10.11
from 10-K 7 pages Promissory Note
12/34/56
EX-10.4
from 10-K 10 pages Recitals
12/34/56
EX-10.2
from 10-Q 19 pages TerrAscend Executive Employment Agreement
12/34/56
EX-10.1
from 10-Q 19 pages TerrAscend Executive Employment Agreement
12/34/56
EX-10.8
from 10-Q 16 pages Recitals
12/34/56
EX-10.7
from 10-Q 14 pages Recitals
12/34/56
EX-10.4
from 8-K 17 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because the Company Has Determined That the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed
12/34/56
EX-10.3
from 8-K 46 pages Subscription and Subscriber Information Please Print All Information (Other Than Signatures), as Applicable, in the Space Provided Below
12/34/56
EX-10.2
from 8-K 52 pages Subscription and Subscriber Information Please Print All Information (Other Than Signatures), as Applicable, in the Space Provided Below
12/34/56
EX-10.1
from 8-K 39 pages Subscription and Subscriber Information Please Print All Information (Other Than Signatures), as Applicable, in the Space Provided Below
12/34/56
EX-10.4
from 8-K 17 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because the Company Has Determined That the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm if Publicly Disclosed
12/34/56
EX-10.3
from 8-K 46 pages Subscription and Subscriber Information Please Print All Information (Other Than Signatures), as Applicable, in the Space Provided Below
12/34/56
EX-10.2
from 8-K 52 pages Subscription and Subscriber Information Please Print All Information (Other Than Signatures), as Applicable, in the Space Provided Below
12/34/56